TITLE

IVAX PREVAILS OVER BRISTOL-MEYERS SQUIBB IN U.K. PATENT CASE

PUB. DATE
July 2000
SOURCE
Worldwide Biotech;Jul2000, Vol. 12 Issue 7, p2
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports that Great Britain's Court of Appeals unanimously upheld a 1998 lower court's ruling in favor of IVAX Corp. in which Bristol-Myers Squibb patent relating to the use of Taxol was invalidated.
ACCESSION #
3350542

 

Related Articles

  • JPC sold in merger with IVAX Corp. Chapelle, Tony // Black Enterprise;Sep93, Vol. 24 Issue 2, p15 

    Reports that Johnson Products Co. Inc. was acquired by the Miami-based IVAX Corp. in the summer of 1993. Other dramas which have impacted the company and the Johnson family; End of the company's 39 years of black ownership; Comment from IVAX chairman and CEO Dr. Philip Frost; More.

  • IVAX receives marketing approval for antihistamine.  // Drug Store News;4/7/97, Vol. 19 Issue 7, p61 

    Reports on the US Food and Drug Administration's approval of Ivax Corp.'s Abbreviated New Drug Application for terfenadine tablets USP. Company executive's comments on the approval; Zenit Goldline Pharmaceuticals' support of consumer education.

  • Ivax moves forward to bolster business unit sales performance. Popolillo, Melissa C. // Drug Store News;6/22/98, Vol. 20 Issue 9, pCP8 

    Discloses the efforts of drug firm Ivax Corp. to improve the operations of its business units. Hiring of Schroders to explore feasibility of initial public offering; Establishment of subsidiary firm; Possible change of name of parent firm to IVX BioSciences.

  • Ivax considers divesting specialties. Plishner, Emily S. // Chemical Week;12/22/1993, Vol. 153 Issue 24, p12 

    Reports on Ivax Corp.'s consideration of divesting its specialty chemicals business. Desire to maintain a balance between proprietary and generic drug products; 1992 revenues; Ivax as leading supplier of chemicals for use on denim fabrics; Specialty chemical earnings before depreciation and...

  • Ivax Corp. Rankin, Ken // Drug Store News;8/18/97, Vol. 19 Issue 13, pCP16 

    Profiles Miami, Florida-based generic drug company Ivax Corp. Contact information; Financial performance; Business profile.

  • Ivax gets drug OK.  // Chemical Market Reporter;03/10/97, Vol. 251 Issue 10, p16 

    Announces the final marketing approval granted to Ivax Corp. for etodolac and acyclovir by the Food and Drug Administration.

  • The Nonmanufacturing Patent Owner: Toward a Theory of Efficient Infringment. Turner, Julie S. // California Law Review;Jan1998, Vol. 86 Issue 1, p179 

    Explores the justification and goals of the patent law, which provides relief against infringers, in the United States. Economic theories that are applied to the patent law; Argument that the injunctive relief is antithetical to the goals of the law and economically inefficient; Model proposed...

  • Up-to-date news for patent seekers. Rifkin, Jane M. // Diversity Suppliers & Business Magazine;Winter95, Vol. 4 Issue 1, p36 

    Looks at the Provisional Patent Application (PPA) which was approved by congress. How Individual inventors show their inventions to potential manufactures without fear of having ideas stolen; Inventors Protection Act of 1995.

  • Legal changes expand patent protection. Meadows, James H. // Machine Design;1/11/96, Vol. 68 Issue 1, p126 

    Reports on the legal changes that expand patent protection for inventors and institutions in the United States. Low-cost mechanisms for entering the global patent system; Procedures for filing a provisional patent provision; Criteria for provisional applications; Advantages of the legal changes.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics